BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36653380)

  • 1. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation.
    An Y; Zhao X; Zhang Z; Xia Z; Yang M; Ma L; Zhao Y; Xu G; Du S; Wu X; Zhang S; Hong X; Jin X; Sun K
    Nat Commun; 2023 Jan; 14(1):287. PubMed ID: 36653380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclease deficiencies alter plasma cell-free DNA methylation profiles.
    Han DSC; Ni M; Chan RWY; Wong DKL; Hiraki LT; Volpi S; Jiang P; Lui KO; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2021 Nov; 31(11):2008-2021. PubMed ID: 34470801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of methylation status using WGS data of plasma cfDNA for multi-cancer early detection (MCED).
    Cui P; Zhou X; Xu S; He W; Huang G; Xiong Y; Zhang C; Chang T; Feng M; Lai H; Pan Y
    Clin Epigenetics; 2024 Feb; 16(1):34. PubMed ID: 38414068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
    Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Enzymatically Converted Cell-Free DNA (cfDNA) Data for Copy Number Variation-Linked Fragmentation Analysis Allows for Early Colorectal Cancer Detection.
    Černoša I; Trincado-Alonso F; Canal-Noguer P; Kruusmaa K; Perera-Lluna A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing.
    Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q
    Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics.
    Peng X; Li HD; Wu FX; Wang J
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32427285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
    Gai W; Sun K
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
    Ivanov M; Baranova A; Butler T; Spellman P; Mileyko V
    BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S1. PubMed ID: 26693644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology.
    Stanley KE; Jatsenko T; Tuveri S; Sudhakaran D; Lannoo L; Van Calsteren K; de Borre M; Van Parijs I; Van Coillie L; Van Den Bogaert K; De Almeida Toledo R; Lenaerts L; Tejpar S; Punie K; Rengifo LY; Vandenberghe P; Thienpont B; Vermeesch JR
    Nat Commun; 2024 Mar; 15(1):2220. PubMed ID: 38472221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing.
    Zhang H; Dong P; Guo S; Tao C; Chen W; Zhao W; Wang J; Cheung R; Villanueva A; Fan J; Ding H; Schrodi SJ; Zhang D; Zeng C
    BMC Med; 2020 Aug; 18(1):200. PubMed ID: 32741373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer.
    Wang J; Niu Y; Yang M; Shu L; Wang H; Wu X; He Y; Chen P; Zhong G; Tang Z; Zhang S; Guo Q; Wang Y; Yu L; Gou D
    Epigenetics Chromatin; 2023 Sep; 16(1):33. PubMed ID: 37740218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection.
    Li Y; Xu J; Chen C; Lu Z; Wan D; Li D; Li JS; Sorg AJ; Roberts CC; Mahajan S; Gallant MA; Pinkoviezky I; Cui Y; Taggart DJ; Li W
    Genome Med; 2024 Jan; 16(1):9. PubMed ID: 38225592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
    Zhou Z; Ma ML; Chan RWY; Lam WKJ; Peng W; Gai W; Hu X; Ding SC; Ji L; Zhou Q; Cheung PPH; Yu SCY; Teoh JYC; Szeto CC; Wong J; Wong VWS; Wong GLH; Chan SL; Hui EP; Ma BBY; Chan ATC; Chiu RWK; Chan KCA; Lo YMD; Jiang P
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2220982120. PubMed ID: 37075072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic analysis of cell-free DNA by fragmentomic profiling.
    Zhou Q; Kang G; Jiang P; Qiao R; Lam WKJ; Yu SCY; Ma ML; Ji L; Cheng SH; Gai W; Peng W; Shang H; Chan RWY; Chan SL; Wong GLH; Hiraki LT; Volpi S; Wong VWS; Wong J; Chiu RWK; Chan KCA; Lo YMD
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2209852119. PubMed ID: 36288287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.